⌘K

Login Start Free

Home/Filings/4/0001264124-04-000257

4//SEC Filing

DATA JOANN L 4

Accession 0001264124-04-000257

CIK 0000881464other

View on SEC.gov Company Profile

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 5:56 PM ET

Size

8.4 KB

Accession

0001264124-04-000257

Insider Transaction Report

Form 4

Period: 2004-12-14

AMYLIN PHARMACEUTICALS INCAMLN

Sr VP Regulatory Affairs & QA

Transactions

Exercise/Conversion
Common Stock
2004-12-14$5.73/sh+13,125$75,206→ 75,363 total
Tax Payment
Common Stock
2004-12-14$22.74/sh−3,307$75,201→ 72,056 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2004-12-14−13,125→ 0 total
Exercise: $5.73From: 2004-12-14Exp: 2011-10-04→ Common Stock (13,125 underlying)

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

AMYLIN PHARMACEUTICALS INC

CIK 0000881464

Entity typeother

Related Parties

1

filerCIK 0001236396

Filing Metadata

Form type: 4
Filed: Dec 14, 7:00 PM ET
Accepted: Dec 15, 5:56 PM ET
Size: 8.4 KB

View on SEC.gov